dc.creatorKarara, Armando Luis
dc.creatorBumaschny, Viviana Florencia
dc.creatorFiszman, Gabriel Leon
dc.creatorCasais, Cecilia C.
dc.creatorGlikin, Gerardo Claudio
dc.creatorFinocchiaro, Liliana Maria Elena
dc.date.accessioned2019-07-18T18:16:36Z
dc.date.accessioned2022-10-15T11:40:13Z
dc.date.available2019-07-18T18:16:36Z
dc.date.available2022-10-15T11:40:13Z
dc.date.created2019-07-18T18:16:36Z
dc.date.issued2002-12
dc.identifierKarara, Armando Luis; Bumaschny, Viviana Florencia; Fiszman, Gabriel Leon; Casais, Cecilia C.; Glikin, Gerardo Claudio; et al.; Lipofection of early passages of cell cultures derived from murine adenocarcinomas: In vitro and ex vivo testing of the thymidine kinase/ganciclovir system; Nature Publishing Group; Cancer Gene Therapy; 9; 1; 12-2002; 96-99
dc.identifier0929-1903
dc.identifierhttp://hdl.handle.net/11336/79812
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4381915
dc.description.abstractEarly passages of cultured cells derived from four spontaneous Balb/c murine adenocarcinomas were used to explore the feasibility of a nonviral HSVtk-based suicide gene therapy system. After lipofection with pCMVtk, the transiently HSVtk expressing P07 (lung), M3, M05, and M38 (mammary gland) cells were, respectively, about 130-, 30-, 120-, and 170-fold more sensitive to ganciclovir (GCV) in vitro than their respective controls. Eighty percent of Balb/c mice subcutaneously inoculated with ex vivo pCMVtk-lipofected P07 cells, followed by intraperitoneal GCV injection for 7 days, displayed a complete inhibition of tumor growth for over 70 days. Control animals started to display tumors 13 days after inoculation. We present evidence showing that early passages of cultured tumor cells can efficiently express lipofected genes and that they are sensitive to the lipoplex-mediated HSVtk/GCV system.
dc.languageeng
dc.publisherNature Publishing Group
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pubmed/11916249
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1038/sj.cgt.7700417
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.nature.com/articles/7700417
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectEARLY PASSAGES OF CELL CULTURES
dc.subjectGANCICLOVIR
dc.subjectGENE THERAPY
dc.subjectLIPOFECTION
dc.subjectMURINE ADENOCARCINOMA
dc.subjectTHYMIDINE KINASE
dc.titleLipofection of early passages of cell cultures derived from murine adenocarcinomas: In vitro and ex vivo testing of the thymidine kinase/ganciclovir system
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución